FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1522113235> ?p ?o ?g. }

• W1522113235 endingPage "1063" @default.
• W1522113235 startingPage "1051" @default.
• W1522113235 abstract "The aim of the present study was to evaluate the pharmacokinetics/pharmacodynamics (PK/PD), safety and tolerability of single intravenous (IV) doses of PF-05231023, a long acting fibroblast growth factor 21 (FGF21) analogue being developed for the treatment of type 2 diabetes mellitus (T2DM).T2DM subjects (glycosylated haemoglobin: 7.0-10.5%; on stable metformin therapy and/or diet and exercise) were randomized to receive a single dose of placebo or PF-05231023 (0.5-200 mg). Safety evaluations were performed up to 14 days after dosing. PK and PD endpoints were measured and a PK/PD model was developed for triglyceride - an early marker of drug activity.No antidrug antibody or serious adverse events (AEs) were observed. The most frequent AEs were gastrointestinal but were generally mild. Plasma PF-05231023 levels peaked immediately post-IV dosing, with mean terminal half-lives of 6.5-7.7 h and 66.5- 96.6 h for intact C- and N-termini, respectively. Intact C-terminus exposures increased proportionally with increasing dose, whereas N-terminus exposures appeared to trend higher than dose-proportionally. Although no apparent effect on plasma glucose was seen, dose-dependent decreases in triglyceride were observed, with a maximum reduction of 48.5 ± 10.0% (mean ± standard deviation) for the 200 mg dose compared with a reduction of 19.1 ± 26.4% for placebo, demonstrating proof of pharmacology. Moreover, a reduction in total cholesterol and low-density lipoprotein cholesterol and an increase in high-density lipoprotein cholesterol were observed in the high-dose groups.Single IV doses of PF-05231023 up to 200 mg were generally safe and well tolerated by subjects with T2DM. The observed early sign of pharmacology supports further clinical testing of PF-05231023 upon repeated administration." @default.
• W1522113235 created "2016-06-24" @default.
• W1522113235 creator A5000421981 @default.
• W1522113235 creator A5004497783 @default.
• W1522113235 creator A5031439207 @default.
• W1522113235 creator A5032257419 @default.
• W1522113235 creator A5033111915 @default.
• W1522113235 creator A5037077908 @default.
• W1522113235 creator A5048727954 @default.
• W1522113235 creator A5088159366 @default.
• W1522113235 date "2015-07-29" @default.
• W1522113235 modified "2023-10-12" @default.
• W1522113235 title "Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study" @default.
• W1522113235 cites W1967221084 @default.
• W1522113235 cites W1970362460 @default.
• W1522113235 cites W2000665430 @default.
• W1522113235 cites W2020958481 @default.
• W1522113235 cites W2029880965 @default.
• W1522113235 cites W2037417878 @default.
• W1522113235 cites W2038863889 @default.
• W1522113235 cites W2046645679 @default.
• W1522113235 cites W2056560462 @default.
• W1522113235 cites W2062842771 @default.
• W1522113235 cites W2077177154 @default.
• W1522113235 cites W2081276121 @default.
• W1522113235 cites W2102454657 @default.
• W1522113235 cites W2119351413 @default.
• W1522113235 cites W2123946565 @default.
• W1522113235 cites W2131044927 @default.
• W1522113235 cites W2165698647 @default.
• W1522113235 cites W2188846692 @default.
• W1522113235 cites W2196423560 @default.
• W1522113235 cites W2271771390 @default.
• W1522113235 cites W2302447233 @default.
• W1522113235 cites W2337454357 @default.
• W1522113235 doi "https://doi.org/10.1111/bcp.12676" @default.
• W1522113235 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4631178" @default.
• W1522113235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25940675" @default.
• W1522113235 hasPublicationYear "2015" @default.
• W1522113235 type Work @default.
• W1522113235 sameAs 1522113235 @default.
• W1522113235 citedByCount "81" @default.
• W1522113235 countsByYear W15221132352015 @default.
• W1522113235 countsByYear W15221132352016 @default.
• W1522113235 countsByYear W15221132352017 @default.
• W1522113235 countsByYear W15221132352018 @default.
• W1522113235 countsByYear W15221132352019 @default.
• W1522113235 countsByYear W15221132352020 @default.
• W1522113235 countsByYear W15221132352021 @default.
• W1522113235 countsByYear W15221132352022 @default.
• W1522113235 countsByYear W15221132352023 @default.
• W1522113235 crossrefType "journal-article" @default.
• W1522113235 hasAuthorship W1522113235A5000421981 @default.
• W1522113235 hasAuthorship W1522113235A5004497783 @default.
• W1522113235 hasAuthorship W1522113235A5031439207 @default.
• W1522113235 hasAuthorship W1522113235A5032257419 @default.
• W1522113235 hasAuthorship W1522113235A5033111915 @default.
• W1522113235 hasAuthorship W1522113235A5037077908 @default.
• W1522113235 hasAuthorship W1522113235A5048727954 @default.
• W1522113235 hasAuthorship W1522113235A5088159366 @default.
• W1522113235 hasBestOaLocation W15221132351 @default.
• W1522113235 hasConcept C111113717 @default.
• W1522113235 hasConcept C112705442 @default.
• W1522113235 hasConcept C126322002 @default.
• W1522113235 hasConcept C134018914 @default.
• W1522113235 hasConcept C142724271 @default.
• W1522113235 hasConcept C197934379 @default.
• W1522113235 hasConcept C204787440 @default.
• W1522113235 hasConcept C27081682 @default.
• W1522113235 hasConcept C2777288759 @default.
• W1522113235 hasConcept C2778163477 @default.
• W1522113235 hasConcept C2778375690 @default.
• W1522113235 hasConcept C2778913445 @default.
• W1522113235 hasConcept C2780323712 @default.
• W1522113235 hasConcept C555293320 @default.
• W1522113235 hasConcept C71924100 @default.
• W1522113235 hasConcept C98274493 @default.
• W1522113235 hasConceptScore W1522113235C111113717 @default.
• W1522113235 hasConceptScore W1522113235C112705442 @default.
• W1522113235 hasConceptScore W1522113235C126322002 @default.
• W1522113235 hasConceptScore W1522113235C134018914 @default.
• W1522113235 hasConceptScore W1522113235C142724271 @default.
• W1522113235 hasConceptScore W1522113235C197934379 @default.
• W1522113235 hasConceptScore W1522113235C204787440 @default.
• W1522113235 hasConceptScore W1522113235C27081682 @default.
• W1522113235 hasConceptScore W1522113235C2777288759 @default.
• W1522113235 hasConceptScore W1522113235C2778163477 @default.
• W1522113235 hasConceptScore W1522113235C2778375690 @default.
• W1522113235 hasConceptScore W1522113235C2778913445 @default.
• W1522113235 hasConceptScore W1522113235C2780323712 @default.
• W1522113235 hasConceptScore W1522113235C555293320 @default.
• W1522113235 hasConceptScore W1522113235C71924100 @default.
• W1522113235 hasConceptScore W1522113235C98274493 @default.
• W1522113235 hasFunder F4320307765 @default.
• W1522113235 hasIssue "5" @default.
• W1522113235 hasLocation W15221132351 @default.
• W1522113235 hasLocation W15221132352 @default.
• W1522113235 hasLocation W15221132353 @default.

• next